Assessing patient experience with a new rotation system during cancer treatment
Nano-X: Patient Experience and Acceptance of Horizontal Rotation
NA · University of Sydney · NCT02995603
This study tests how comfortable and anxious cancer patients feel when using a new rotation system during treatment to see if it can improve their experience.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 100 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University of Sydney (other) |
| Locations | 1 site (Randwick, New South Wales) |
| Trial ID | NCT02995603 on ClinicalTrials.gov |
What this trial studies
This study evaluates how patients with cancer experience and accept being rotated at different speeds using the Nano-X patient rotation system. Participants will attend two sessions where they will complete psychometric questionnaires measuring claustrophobia, anxiety, and motion sickness before and after being rotated. The rotations will simulate typical radiotherapy treatments, allowing researchers to assess the impact of rotation speed on patient comfort and anxiety levels. The goal is to gather data that could improve patient experiences during radiotherapy.
Who should consider this trial
Good fit: Ideal candidates include adults aged 18 and older with any stage of cancer who are currently or have previously received radiotherapy.
Not a fit: Patients who are pregnant, mentally impaired, or have severe vertigo may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance patient comfort and acceptance of radiotherapy treatments, potentially improving treatment adherence.
How similar studies have performed: While there have been studies on patient comfort during radiotherapy, the specific approach of using a rotation system is relatively novel and has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. A diagnosis of cancer, any stage 2. ≥18 years of age 3. Eastern Cooperative Oncology Group (ECOG) status 0-2 4. Currently or previously being treated with radiotherapy 5. Any prior therapy allowed 6. Willing and able to comply with all study requirements 7. Must be able to read and complete questionnaires in English 8. Signed, written informed consent Exclusion Criteria: 1. Pregnant women 2. Mentally impaired patients or patients for whom attaining informed consent would be difficult (including language barriers) 3. Severe vertigo or recent diagnosis of Benign Paroxysmal Positioning Vertigo
Where this trial is running
Randwick, New South Wales
- Prince of Wales Hospital — Randwick, New South Wales, Australia (RECRUITING)
Study contacts
- Study coordinator: Shona Silvester
- Email: shona.silvester@sydney.edu.au
- Phone: +61 2 86271185
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Cancer, Radiotherapy, Rotation